ORAL DELIVERY OF ACTIVE COMPOUNDS FOR TREATING GLYCOGEN STORAGE DISEASES
The present disclosure concerns formulations for oral delivery of at least one active agent of a compound according to formula (I) and/or (II) for the treatment of glycogen storage diseases, neurodegenerative disorders and autophagy-related conditions. The formulations are nano- structured formulati...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MUSLEH, Rawan GARTI, Nissim GARTI-LEVI, Sharon ABU-GHOUSH, Reham EDRI, Rotem |
| description | The present disclosure concerns formulations for oral delivery of at least one active agent of a compound according to formula (I) and/or (II) for the treatment of glycogen storage diseases, neurodegenerative disorders and autophagy-related conditions. The formulations are nano- structured formulations for increasing the bioavailability of the active agent after administration.
La présente divulgation concerne des formulations pour l'administration orale d'au moins un agent actif d'un composé selon la formule (I) et/ou (II) pour le traitement de maladies du stockage du glycogène, de troubles neurodégénératifs et d'affections liées à l'autophagie. Les formulations sont des formulations nanostructurées destinées à augmenter la biodisponibilité de l'agent actif après administration. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2024042523A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2024042523A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2024042523A13</originalsourceid><addsrcrecordid>eNrjZPDwD3L0UXBx9fEMcw2KVPB3U3B0DgGyFZz9fQP8Q_1cghXc_IMUQoJcHUM8_dwV3H0inf3dXf0UgkOAOt1dFVw8g10dg12DeRhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfLi_kYGRiYGJkamRsaOhMXGqAMCqLc0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ORAL DELIVERY OF ACTIVE COMPOUNDS FOR TREATING GLYCOGEN STORAGE DISEASES</title><source>esp@cenet</source><creator>MUSLEH, Rawan ; GARTI, Nissim ; GARTI-LEVI, Sharon ; ABU-GHOUSH, Reham ; EDRI, Rotem</creator><creatorcontrib>MUSLEH, Rawan ; GARTI, Nissim ; GARTI-LEVI, Sharon ; ABU-GHOUSH, Reham ; EDRI, Rotem</creatorcontrib><description>The present disclosure concerns formulations for oral delivery of at least one active agent of a compound according to formula (I) and/or (II) for the treatment of glycogen storage diseases, neurodegenerative disorders and autophagy-related conditions. The formulations are nano- structured formulations for increasing the bioavailability of the active agent after administration.
La présente divulgation concerne des formulations pour l'administration orale d'au moins un agent actif d'un composé selon la formule (I) et/ou (II) pour le traitement de maladies du stockage du glycogène, de troubles neurodégénératifs et d'affections liées à l'autophagie. Les formulations sont des formulations nanostructurées destinées à augmenter la biodisponibilité de l'agent actif après administration.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240229&DB=EPODOC&CC=WO&NR=2024042523A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240229&DB=EPODOC&CC=WO&NR=2024042523A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MUSLEH, Rawan</creatorcontrib><creatorcontrib>GARTI, Nissim</creatorcontrib><creatorcontrib>GARTI-LEVI, Sharon</creatorcontrib><creatorcontrib>ABU-GHOUSH, Reham</creatorcontrib><creatorcontrib>EDRI, Rotem</creatorcontrib><title>ORAL DELIVERY OF ACTIVE COMPOUNDS FOR TREATING GLYCOGEN STORAGE DISEASES</title><description>The present disclosure concerns formulations for oral delivery of at least one active agent of a compound according to formula (I) and/or (II) for the treatment of glycogen storage diseases, neurodegenerative disorders and autophagy-related conditions. The formulations are nano- structured formulations for increasing the bioavailability of the active agent after administration.
La présente divulgation concerne des formulations pour l'administration orale d'au moins un agent actif d'un composé selon la formule (I) et/ou (II) pour le traitement de maladies du stockage du glycogène, de troubles neurodégénératifs et d'affections liées à l'autophagie. Les formulations sont des formulations nanostructurées destinées à augmenter la biodisponibilité de l'agent actif après administration.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPDwD3L0UXBx9fEMcw2KVPB3U3B0DgGyFZz9fQP8Q_1cghXc_IMUQoJcHUM8_dwV3H0inf3dXf0UgkOAOt1dFVw8g10dg12DeRhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfLi_kYGRiYGJkamRsaOhMXGqAMCqLc0</recordid><startdate>20240229</startdate><enddate>20240229</enddate><creator>MUSLEH, Rawan</creator><creator>GARTI, Nissim</creator><creator>GARTI-LEVI, Sharon</creator><creator>ABU-GHOUSH, Reham</creator><creator>EDRI, Rotem</creator><scope>EVB</scope></search><sort><creationdate>20240229</creationdate><title>ORAL DELIVERY OF ACTIVE COMPOUNDS FOR TREATING GLYCOGEN STORAGE DISEASES</title><author>MUSLEH, Rawan ; GARTI, Nissim ; GARTI-LEVI, Sharon ; ABU-GHOUSH, Reham ; EDRI, Rotem</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2024042523A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MUSLEH, Rawan</creatorcontrib><creatorcontrib>GARTI, Nissim</creatorcontrib><creatorcontrib>GARTI-LEVI, Sharon</creatorcontrib><creatorcontrib>ABU-GHOUSH, Reham</creatorcontrib><creatorcontrib>EDRI, Rotem</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MUSLEH, Rawan</au><au>GARTI, Nissim</au><au>GARTI-LEVI, Sharon</au><au>ABU-GHOUSH, Reham</au><au>EDRI, Rotem</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ORAL DELIVERY OF ACTIVE COMPOUNDS FOR TREATING GLYCOGEN STORAGE DISEASES</title><date>2024-02-29</date><risdate>2024</risdate><abstract>The present disclosure concerns formulations for oral delivery of at least one active agent of a compound according to formula (I) and/or (II) for the treatment of glycogen storage diseases, neurodegenerative disorders and autophagy-related conditions. The formulations are nano- structured formulations for increasing the bioavailability of the active agent after administration.
La présente divulgation concerne des formulations pour l'administration orale d'au moins un agent actif d'un composé selon la formule (I) et/ou (II) pour le traitement de maladies du stockage du glycogène, de troubles neurodégénératifs et d'affections liées à l'autophagie. Les formulations sont des formulations nanostructurées destinées à augmenter la biodisponibilité de l'agent actif après administration.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2024042523A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | ORAL DELIVERY OF ACTIVE COMPOUNDS FOR TREATING GLYCOGEN STORAGE DISEASES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T02%3A24%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MUSLEH,%20Rawan&rft.date=2024-02-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2024042523A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |